Bonnet Fernand

See author's contact details

Main Referenced Co-authors

Scheen, André (2)

Main Referenced Keywords

Type 2 diabetes (2); Antidiabetic agents (1); Cardiovascular disease (1); Chronic kidney disease (1); Clinical trial (1);

Main Referenced Disciplines

Endocrinology, metabolism & nutrition (2)

Pharmacy, pharmacology & toxicology (2)

Publications (total 2)

Search in publications

The most downloaded

1 downloads

Bonnet, F., & Scheen, A. (2017). Impact of glucose-lowering therapies on risk of stroke in type 2 diabetes. Diabetes and Metabolism. doi:10.1016/j.diabet.2017.04.004 https://hdl.handle.net/2268/216136

The most cited

206 citations (Scopus®)

Bonnet, F., & Scheen, A. (2018). Effects of SGLT2 inhibitors on systemic and tissue low-grade inflammation: The potential contribution to diabetes complications and cardiovascular disease. Diabetes and Metabolism. doi:10.1016/j.diabet.2018.09.005 https://hdl.handle.net/2268/230403

https://hdl.handle.net/2268/230403

Peer Reviewed verified by ORBi

Bonnet, F., & Scheen, A. (2017). Impact of glucose-lowering therapies on risk of stroke in type 2 diabetes. Diabetes and Metabolism. doi:10.1016/j.diabet.2017.04.004

https://hdl.handle.net/2268/216136

Peer Reviewed verified by ORBi